We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Combining CRISPR With Drug Discovery to Understand Treatment Efficacy

News   Apr 16, 2019 | Original story from Harvard University

 
Combining CRISPR With Drug Discovery to Understand Treatment Efficacy

Cancerous cells (dark purple) start to spread in a patient's bone marrow. Mutated genes often spark rampant AML cancer growth. Credit: The Armed Forces Institute of Pathology (AFIP)

 
 
 

RELATED ARTICLES

Potential Cancer Players Uncovered by Tumor Protein Analysis

News

Looking to gain a deeper understanding of cancer, a team conducted an extensive computational analysis of the similarities and differences in the entire set of proteins, called the proteome, of more than 500 cancers from five different tissue sites.

READ MORE

The Dangers Lurking Behind Certain Biologics

News

The surprising role of an immune cell that explains some of biologic drugs' side effects could lead to better treatments for persistent infections and cancer.

READ MORE

The Right Mouse Is Key for Huntington's Drug Development

News

Scientists evaluated mouse models used for developing new treatments for mood disorders associated with Huntington's disease and recommend which are most relevant and have greater potential for success.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE